Samuel, Sara <br/><br/>
VSV oncolysis in combination with the BCL-2 inhibitor obatoclax overcomes apoptosis resistance in chronic lymphocytic leukemia.  [electronic resource] 

 -  Molecular therapy : the journal of the American Society of Gene Therapy  Dec 2010 
 - 2094-103 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1525-0024 
<br/><br/><label>Standard No.: </label>10.1038/mt.2010.188  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis<br/>Cell Line, Tumor<br/>Combined Modality Therapy<br/>Disease Models, Animal<br/>Female<br/>Genetic Therapy<br/>Humans<br/>Indoles<br/>Leukemia, Lymphocytic, Chronic, B-Cell--therapy<br/>Mice<br/>Mice, SCID<br/>Proto-Oncogene Proteins c-bcl-2--antagonists & inhibitors<br/>Pyrroles--pharmacology<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Vesiculovirus--physiology